Citation: P. Hilgard et R. Stockert, Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes, HEPATOLOGY, 32(5), 2000, pp. 1069-1077
Authors:
Ahmed, SNS
Tavan, D
Pichoud, C
Berby, F
Stuyver, L
Johnson, M
Merle, P
Abidi, H
Trepo, C
Zoulim, F
Citation: Sns. Ahmed et al., Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B, HEPATOLOGY, 32(5), 2000, pp. 1078-1088
Authors:
Yu, SH
Nagayama, K
Enomoto, N
Izumi, N
Marumo, F
Sato, C
Citation: Sh. Yu et al., Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C, HEPATOLOGY, 32(5), 2000, pp. 1089-1095
Authors:
Schlager, F
Schaefer, S
Metzler, M
Gratzki, N
Lampert, F
Gerlich, WH
Repp, R
Citation: F. Schlager et al., Quantitative DNA fragment analysis for detecting low amounts of hepatitis B virus deletion mutants in highly viremic carriers, HEPATOLOGY, 32(5), 2000, pp. 1096-1105
Authors:
Sagnelli, E
Coppola, N
Scolastico, C
Filippini, P
Santantonio, T
Stroffolini, T
Piccinino, F
Citation: E. Sagnelli et al., Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis, HEPATOLOGY, 32(5), 2000, pp. 1106-1110
Authors:
Webster, GJM
Reignat, S
Maini, MK
Whalley, SA
Ogg, GS
King, A
Brown, D
Amlot, PL
Williams, R
Vergani, D
Dusheiko, GM
Bertoletti, A
Citation: Gjm. Webster et al., Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms, HEPATOLOGY, 32(5), 2000, pp. 1117-1124
Authors:
Sreekumar, R
Gonzalez-Koch, A
Maor-Kendler, Y
Batts, K
Moreno-Luna, L
Poterucha, J
Burgart, L
Wiesner, R
Kremers, W
Rosen, C
Charlton, MR
Citation: R. Sreekumar et al., Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation, HEPATOLOGY, 32(5), 2000, pp. 1125-1130
Authors:
Poynard, T
McHutchison, J
Davis, GL
Esteban-Mur, R
Goodman, Z
Bedossa, P
Albrecht, J
Citation: T. Poynard et al., Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C, HEPATOLOGY, 32(5), 2000, pp. 1131-1137
Authors:
Chayama, K
Suzuki, F
Tsubota, A
Kobayashi, M
Arase, Y
Saitoh, S
Suzuki, Y
Murashima, N
Ikeda, K
Takahashi, N
Kinoshita, M
Kumada, H
Citation: K. Chayama et al., Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy, HEPATOLOGY, 32(5), 2000, pp. 1138-1144
Authors:
Lok, ASF
Hussain, M
Cursano, C
Margotti, M
Gramenzi, A
Grazi, GL
Jovine, E
Benardi, M
Andreone, P
Citation: Asf. Lok et al., Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy, HEPATOLOGY, 32(5), 2000, pp. 1145-1153
Authors:
Chun, YK
Kim, JY
Woo, HJ
Oh, SM
Kang, IS
Ha, J
Kim, SS
Citation: Yk. Chun et al., No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection, HEPATOLOGY, 32(5), 2000, pp. 1154-1162
Citation: Sw. Cho et al., Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy, HEPATOLOGY, 32(5), 2000, pp. 1163-1169
Citation: Th. Baron, Chemotherapy impregnated plastic biliary endoprostheses: One small step for man(agement) of cholangiocarcinoma ..., HEPATOLOGY, 32(5), 2000, pp. 1170-1171
Citation: F. Zoulim et C. Trepo, Is lamivudine effective on precore/core promoter mutants of hepatitis B virus?, HEPATOLOGY, 32(5), 2000, pp. 1172-1174
Citation: Mp. Curry et M. Koziel, The dynamics of the immune response in acute hepatitis B: New lessons using new techniques, HEPATOLOGY, 32(5), 2000, pp. 1177-1179
Authors:
Kocak, N
Saltik, IN
Ozen, H
Yuce, A
Gurakan, F
Citation: N. Kocak et al., Lamivudine treatment for children with interferon refractory chronic hepatitis B - Reply, HEPATOLOGY, 32(5), 2000, pp. 1180-1180
Citation: American Association for the Study of Liver Diseases (AASLD) - 51st AnnualMeeting and Postgraduate Courses - October 21-31, 2000 Wyndham Anatole Hotel - Dallas, Texas - Abstracts, HEPATOLOGY, 32(4), 2000, pp. CP1-CP1